Egide FY25 returns to positive EBITDA at EUR 0.7 million; revenue rises 4% to EUR 31.34 million

  • Egide posted 2025 revenue of EUR 31.34 million, up 4%, while EBITDA swung to a profit of EUR 0.7 million.
  • Net loss attributable to shareholders widened to EUR 3.11 million, hit by Santier.
  • Working capital requirement improved to 36 days from 62 days, while net financial debt fell to EUR 5.4 million.
  • North American operations are being consolidated at Cambridge, Maryland; Santier’s San Diego production stopped in late April 2026, with site closure due in summer 2026.
  • CEO Ignace Dupon said 2025 marked a return to positive EBITDA, with early benefits from tighter operations and a continued focus on critical applications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Egide SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606260200OMX_____CNEWS_FR_GNW1001209687_fr) on June 26, 2026, and is solely responsible for the information contained therein.